Bradley & Co Private Wealth Management’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,295
Closed -$128K 172
2022
Q4
$128K Hold
5,295
0.16% 40
2022
Q3
$125K Buy
+5,295
New +$134K 0.15% 48

Other funds holding IBDX

Bradley & Co Private Wealth Management's IBDX Position: Q1 2023 in Review

Bradley & Co Private Wealth Management sold out of iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q1 2023, closing a stake of 5,295 shares — an estimated $128K sold.

Bradley & Co Private Wealth Management first reported a position in IBDX in Q3 2022 and held it in 2 quarters. The position peaked at $128K in Q4 2022. 36 funds tracked by Wall St. Rank hold IBDX as of Q1 2023.

  • Bradley & Co Private Wealth Management reported no remaining iShares iBonds Dec 2032 Term Corporate ETF position as of Q1 2023 after selling out during the quarter.
  • Bradley & Co Private Wealth Management sold 5,295 iShares iBonds Dec 2032 Term Corporate ETF shares in Q1 2023, an estimated $128K.
  • Bradley & Co Private Wealth Management first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2022 and held it in 2 quarters.
  • Bradley & Co Private Wealth Management's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $128K in Q4 2022.
  • 36 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2023.

Based on Bradley & Co Private Wealth Management's 13F filing for Q1 2023, filed 9 May 2023.